Literature DB >> 2400216

Trends in the incidence of Reye's syndrome and the use of aspirin.

J D Porter1, P H Robinson, J F Glasgow, J H Banks, S M Hall.   

Abstract

In 1986 there was a public warning in the United Kingdom about a link between the consumption of aspirin and Reye's syndrome. To find out if the use of aspirin and paracetamol in children had altered, and whether the incidence of Reye's syndrome had changed since a previous study, parents were interviewed in Belfast and London, and the British Reye's Syndrome Surveillance System data were reviewed. Children with febrile illnesses were 17 times more likely to have received aspirin before admission to hospital in 1985/6 compared with 1988/9. Only 21 Belfast parents (40%) and 13 London parents (27%) had heard of Reye's syndrome and only 12 in Belfast (23%) and seven in London (15%) knew of its association with aspirin, suggesting a continuing need for public education. Cases of Reye's syndrome declined both in numbers (from a peak of 79 in 1983/4 to 19 in 1988/9) and in median age. Of the 418 reported cases, the diagnosis was subsequently revised in 89, most often (in 31 of 89, 36%) to 'inborn errors of metabolism'.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2400216      PMCID: PMC1792465          DOI: 10.1136/adc.65.8.826

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  15 in total

1.  ENCEPHALOPATHY AND FATTY DEGENERATION OF THE VISCERA. A DISEASE ENTITY IN CHILDHOOD.

Authors:  R D REYE; G MORGAN; J BARAL
Journal:  Lancet       Date:  1963-10-12       Impact factor: 79.321

Review 2.  Progress in Reye syndrome: epidemiology, biochemical mechanisms and animal models.

Authors:  L Kilpatrick-Smith; D E Hale; S D Douglas
Journal:  Dig Dis       Date:  1989       Impact factor: 2.404

3.  Decreasing trends in Reye syndrome and aspirin use in Michigan, 1979 to 1984.

Authors:  P L Remington; D Rowley; H McGee; W N Hall; A S Monto
Journal:  Pediatrics       Date:  1986-01       Impact factor: 7.124

4.  Aetiology of Reye's syndrome.

Authors:  M H Bellman; S M Hall
Journal:  Arch Dis Child       Date:  1983-09       Impact factor: 3.791

5.  Aspirin as a risk factor in Reye's syndrome.

Authors:  R J Waldman; W N Hall; H McGee; G Van Amburg
Journal:  JAMA       Date:  1982-06-11       Impact factor: 56.272

6.  Reye's syndrome and medication use.

Authors:  T J Halpin; F J Holtzhauer; R J Campbell; L J Hall; A Correa-Villaseñor; R Lanese; J Rice; E S Hurwitz
Journal:  JAMA       Date:  1982-08-13       Impact factor: 56.272

7.  Public Health Service study on Reye's syndrome and medications. Report of the pilot phase.

Authors:  E S Hurwitz; M J Barrett; D Bregman; W J Gunn; L B Schonberger; W R Fairweather; J S Drage; J R LaMontagne; R A Kaslow; D B Burlington
Journal:  N Engl J Med       Date:  1985-10-03       Impact factor: 91.245

8.  Reye's syndrome and salicylate use.

Authors:  K M Starko; C G Ray; L B Dominguez; W L Stromberg; D F Woodall
Journal:  Pediatrics       Date:  1980-12       Impact factor: 7.124

9.  Preadmission antipyretics in Reye's syndrome.

Authors:  S M Hall; P A Plaster; J F Glasgow; P Hancock
Journal:  Arch Dis Child       Date:  1988-07       Impact factor: 3.791

10.  Public Health Service study of Reye's syndrome and medications. Report of the main study.

Authors:  E S Hurwitz; M J Barrett; D Bregman; W J Gunn; P Pinsky; L B Schonberger; J S Drage; R A Kaslow; D B Burlington; G V Quinnan
Journal:  JAMA       Date:  1987-04-10       Impact factor: 56.272

View more
  9 in total

1.  Lesson of the week: Reye's syndrome and aspirin: lest we forget.

Authors:  M C McGovern; J F Glasgow; M C Stewart
Journal:  BMJ       Date:  2001-06-30

2.  Genetic aspects of admissions to a paediatric intensive care unit.

Authors:  D R FitzPatrick; C H Skeoch; J L Tolmie
Journal:  Arch Dis Child       Date:  1991-05       Impact factor: 3.791

3.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  The Canadian Paediatric Surveillance Program: A new opportunity to help shape public health policy.

Authors:  R Stanwick; P Sockett
Journal:  Paediatr Child Health       Date:  2001-05       Impact factor: 2.253

5.  Impact of medicines regulatory risk communications in the UK on prescribing and clinical outcomes: Systematic review, time series analysis and meta-analysis.

Authors:  Christopher J Weatherburn; Bruce Guthrie; Tobias Dreischulte; Daniel R Morales
Journal:  Br J Clin Pharmacol       Date:  2019-12-16       Impact factor: 4.335

Review 6.  Reye's syndrome: the case for a causal link with aspirin.

Authors:  John F T Glasgow
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

7.  The Swiss Paediatric Surveillance Unit (SPSU).

Authors:  H Zimmermann; D Desgrandchamps; G Schubiger
Journal:  Soz Praventivmed       Date:  1995

Review 8.  Paracetamol for treating fever in children.

Authors:  M Meremikwu; A Oyo-Ita
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 9.  Long-term adverse effects of paracetamol - a review.

Authors:  J C McCrae; E E Morrison; I M MacIntyre; J W Dear; D J Webb
Journal:  Br J Clin Pharmacol       Date:  2018-07-20       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.